Cyclooxygenase inhibition in human monocytes increases endotoxin-induced TNFα without affecting cyclooxygenase-2 expression

被引:13
|
作者
Ulcar, R
Peskar, BA
Schuligoi, R
Heinemann, A
Kessler, HH
Santner, BI
Amann, R
机构
[1] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria
[2] Med Univ Graz, Inst Hyg, A-8010 Graz, Austria
基金
奥地利科学基金会;
关键词
NSAID; prostaglandin E-2; TNF alpha; cyclooxygenase; glucocorticoid; monocyte; human;
D O I
10.1016/j.ejphar.2004.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human endotoxin-stimulated adherent monocytes were used in order to determine whether or not NSAIDs influence cyclooxygenase-2 and/or tumor necrosis factor (TNF)alpha expression within the range of inhibitor concentrations that are required to suppress prostaglandin biosynthesis. Exogenous prostaglandin E-2 (IC50<5 nM) inhibited endotoxin-induced TNFalpha rnRNA and protein while, up to I muM. it did not significantly affect cyclooxygenase-2 mRNA expression. Similar results were obtained using the membrane-permeable cAMP analogue db-cAMP. which caused preferential inhibition of TNFalpha expression. Indomethacin or lysine-acetylsalicylic acid concentration-dependently inhibited prostaglandin E2 biosynthesis and, at concentrations causing near-complete inhibition, enhanced TNFa mRNA and protein expression without significantly influencing cyclooxygenase-2 mRNA. fit addition, by facilitating endotoxin-induced TNFalpha expression, indomethacin or lysine-acetylsalicylic acid counteracted dexamethasone-induced inhibition of TNFalpha biosynthesis, thereby exhibiting an effect opposite to that of exogenous prostaglandin E-2. The results suggest that in human endotoxin-stimulated monocytes, NSAIDs can enhance TNFalpha expression through inhibition of cyclooxygenase and the resulting decrease in prostanoid biosynthesis. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 50 条
  • [31] Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation
    Shaw, KN
    Commins, S
    O'Mara, SM
    [J]. BRAIN RESEARCH, 2005, 1038 (02) : 231 - 237
  • [32] Inhibition of TNF-α-induced Cyclooxygenase-2 Expression by Mycobacterium bovis BCG in Human Alveolar Epithelial A549 Cells
    Bansal, K.
    Narayana, Y.
    Balaji, K. N.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 69 (01) : 11 - 19
  • [33] Expression of cyclooxygenase-2 in human lung carcinoma
    Wolff, H
    Saukkonen, K
    Anttila, S
    Karjalainen, A
    Vainio, H
    Ristimäki, A
    [J]. CANCER RESEARCH, 1998, 58 (22) : 4997 - 5001
  • [34] Expression of cyclooxygenase-2 in human prostate cancer
    不详
    [J]. JOURNAL OF ENDOUROLOGY, 2005, 19 : A1 - A1
  • [35] Expression of cyclooxygenase-2 in human gastric carcinoma
    Ristimaki, A
    Honkanen, N
    Jankala, H
    Sipponen, P
    Harkonen, M
    [J]. CANCER RESEARCH, 1997, 57 (07) : 1276 - 1280
  • [36] Cyclooxygenase-2 expression in human thyroid disease
    Lee, K. J.
    Jung, Y. S.
    Kim, W. H.
    Yoon, T. I.
    Joo, H. J.
    Soh, E. Y.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (02) : 111 - 118
  • [37] Cyclooxygenase-2 expression in human pituitary tumors
    Vidal, S
    Kovacs, K
    Bell, D
    Horvath, E
    Scheithauer, BW
    Lloyd, RV
    [J]. CANCER, 2003, 97 (11) : 2814 - 2821
  • [38] Cyclooxygenase-2 expression in the developing human kidney
    Khan, KNM
    Stanfield, KM
    Dannenberg, A
    Seshan, SV
    Baergen, RN
    Baron, DA
    Soslow, RA
    [J]. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2001, 4 (05) : 461 - 466
  • [39] Cyclooxygenase-2 expression in human thyroid disease
    K. J. Lee
    Y. S. Jung
    W. H. Kim
    T. I. Yoon
    H. J. Joo
    E. Y. Soh
    [J]. Journal of Endocrinological Investigation, 2008, 31 : 111 - 118
  • [40] Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
    Yip-Schneider, MT
    Barnard, DS
    Billings, SD
    Cheng, L
    Heilman, DK
    Lin, A
    Marshall, SJ
    Crowell, PL
    Marshall, MS
    Sweeney, CJ
    [J]. CARCINOGENESIS, 2000, 21 (02) : 139 - 146